Page last updated: 2024-08-23

tobramycin and Corneal Angiogenesis

tobramycin has been researched along with Corneal Angiogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sua, AS; Uy, HS; Yu, EN	1

Other Studies

1 other study(ies) available for tobramycin and Corneal Angiogenesis

Article	Year
Histologic findings of bevacizumab-treated human conjunctiva in Stevens-Johnson syndrome. Cornea, 2011, Volume: 30, Issue:11 Topics: Administration, Topical; Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Conjunctival Diseases; Corneal Neovascularization; Dexamethasone; Humans; Male; Ophthalmic Solutions; Stevens-Johnson Syndrome; Tobramycin; Vascular Endothelial Growth Factor A	2011

Article

Year

Histologic findings of bevacizumab-treated human conjunctiva in Stevens-Johnson syndrome.

Cornea, 2011, Volume: 30, Issue:11

Topics: Administration, Topical; Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Conjunctival Diseases; Corneal Neovascularization; Dexamethasone; Humans; Male; Ophthalmic Solutions; Stevens-Johnson Syndrome; Tobramycin; Vascular Endothelial Growth Factor A

2011